Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia

Murray, Nigel P.; Guzman, Eghon; Del Prado, Monica

Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia

dc.contributor.author	Murray, Nigel P.	es
dc.contributor.author	Guzman, Eghon	es
dc.contributor.author	Del Prado, Monica	es
dc.date.accessioned	2021-12-17T13:57:18Z
dc.date.available	2021-12-17T13:57:18Z
dc.date.issued	2021-11
dc.description.abstract	The case report demonstrates the importance of investigating alternative causes of a prolonged APTT in patients with Covid-19. Although Covid-19 is associated with thrombotic complications it is possible that immune dys-regulation associated with SARS-CoV-2 may lead to other coagulation factor inhibitors and a hemorrhagic tendency. Clinical decisions on anticoagulant treatment may be influenced by the APTT and modified in patients with Covid-19. Management of these cases requires the clinical acumen to balance the potential for haemorrhagic and thrombotic complications of SARS-CoV-2 infection. The abnormalidades in the coagulation tests may persist long after clinical remission and resolution of inflammatory markers.	es
dc.identifier.citation	Hematology, Transfusion and Cell Therapy, Vol. 43, N°4, (2021) p. 515-517	es
dc.identifier.doi	https://doi.org/10.1016/j.htct.2021.06.017
dc.identifier.issn	2531-1379
dc.identifier.issne	2531-1387
dc.identifier.orcid	http://orcid.org/0000-0001-8154-8550	es
dc.identifier.uri	http://hdl.handle.net/20.500.12254/2155
dc.language.iso	en	es
dc.publisher	Elsevier	es
dc.rights	Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.subject.other	COVID-19	es
dc.subject.other	Factor XII deficidency	es
dc.title	Transient acquired factor XII deficiency associated with moderately severe Covid-19 pneumonia	en
dc.type	Artículo	es